FDA Inspection 1155209 — Joel Schlessinger, M.D.
The FDA completed an inspection of Joel Schlessinger, M.D. on October 8, 2021 in Omaha, NE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 8, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Omaha, NE (United States)
Additional Details
Clinical Investigator (CI)